SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5ยข to $5 -- Ignore unavailable to you. Want to Upgrade?


To: SG who wrote (43974)12/2/2005 8:48:21 AM
From: rrufff  Read Replies (1) | Respond to of 120413
 
Just so any new reader doesn't get the wrong idea from your post. I believe you and I are in agreement that the scam has been that EMFP has strangely been the subject of 2 bashing pieces in the main stream media, both of which were apparently written by authors who know little or nothing about the company.

The first and more hurtful, as it stopped the rally over a buck, was a Marketwatch.com piece that lumped it in with hurricane plays being pumped after Katrina. Of course, EMFP has nothing to do with hurricanes or rebuilding. The author admitted he knew nothing about the company but that he had seen an email which said it was. What a way for an author, and a respected reporter, to do his business. Now I know why reporters are considered on a plane lower than, shall I say it, (sshhhhh), lawyers.... Disregard that last phrase.

The second was a short piece that indicated the FDA was investigating and that the masks were not effective vs bird flu. The reality is that the FDA is not investigating and has said no such thing. The FDA is not involved with this type of product. Nothing has been approved as curing or stopping bird flu and that includes Tamiflu and any vaccine. It's a guessing game here and, given a choice, those who fear the flu will want a mask, particularly one with a state of the art nano filter.



To: SG who wrote (43974)12/2/2005 8:50:07 AM
From: rrufff  Respond to of 120413
 
EMFP .69 out with a PR indicating new manufacturing facility to meet the huge demand, and also with a paragraph with respect to misleading information in the media. Looks positive, at least long term.

HENDERSON, Nev.--(BUSINESS WIRE)--Dec. 2, 2005--
Emergency Filtration Products, Inc. (EFP) (OTCBB:EMFP)
today announced that it has signed a three year lease on a 13,000
square foot facility in Nogales, Mexico, where it intends to establish
additional production capabilities to meet increased demand for its
NanoMask and NanoMask filters. The Nogales plant will be initially
equipped with spray booths to enhance pre-cut filters with
nanoparticles, six high speed automatic packaging machines and a
filter media cutting machine. EFP expects the Nogales plant to
commence production within 4 to 6 weeks.
Current plans for the Nogales facility, as in its Henderson,
Nevada, plant, are to enhance the filters with nanoparticles and
package the filters hermetically. The company sources pre-cut filters
from its subcontracted manufacturers where filter media is cut to the
company's specifications.

Increasing production capacity is a key component of the company's
growth plans, as EFP will then be able to pursue converting serious
indications of interest (in the NanoMask and NanoMask filters) from
large national and international companies into purchase orders. The
company's existing plant in Henderson, Nevada, does not have the
production capacity itself to meet the potential demand that has been
indicated by a large number of prospective customers.
"We are expanding our NanoMask filter production capacity as
quickly as possible," said Douglas K. Beplate, President & CEO, EFP.
"After meeting with a number of large national and international
prospective customers, it became evident that the scale of orders that
they are contemplating far outstripped the Henderson facility's
production capacity. Accordingly, after reviewing a number of
different production options, we decided to establish production in
Mexico, which has an ample supply of skilled labor and easy
transportation access to the United States and other international
locations."

The company has recently become aware of certain misleading and
inaccurate reports in the media regarding its NanoMask product. In
response, the company is taking action to determine the sources of
such incorrect information and to proceed as necessary to prevent its
dissemination. Accurate and complete information on the NanoMask and
EFP's other products is available on the company's website.

About NanoMask:
(http://emergencyfiltration.com/Products/NanoMask.htm)

EFP's 2H Nano-Enhanced Environmental Mask, the NanoMask relies on
the company's core 2H Technology(TM) filtration system, which utilizes
a combination of hydrophobic or hydrophilic filters able to capture
and isolate bacterial and viral microorganisms with efficiencies of
99.9%. The environmental mask utilizes the company's patented 2H
Technology(TM) and nanotechnology to enhance the capture-and-isolation
characteristics of the filter media.

About Emergency Filtration Products:
(http://www.emergencyfiltration.com/)

EFP is an air filtration products manufacturer who's patented 2H
Technology(TM) filter system has produced filtration efficiencies of
"greater than 99.99%" at a particulate size of 0.027 microns. Its
initial products were developed for the medical market: the Vapor
Isolation Valve(TM) and RespAide(R) CPR Isolation Mask used for
resuscitation of respiratory/cardiac arrest cases; and the 2H
Breathing Circuit Filter for ventilators, respirators and anesthesia
circuitry. Each has received FDA approval. The company also markets an
Automated External Defibrillator Prep Kit featuring RespAide; and the
NanoMask(R), a nanotechnology enhanced environmental mask. In addition
to filtration products, the company supplies Superstat(R), a modified
hemostatic collagen, to the US military for surgery and extreme wound
care.

Safe Harbor Statement:

This release may contain statements that are forward looking. Such
statements are made based upon current expectations that are subject
to risk and uncertainty. EFP does not undertake to update
forward-looking statements in this news release to reflect actual
results of and changes in assumptions or changes in other factors
affecting such forward-looking information. The actual future results
of the company could differ significantly from such forward-looking
statements. Sales may be dependent on EFP's ability to fulfill orders
in a timely fashion as well as the success of future marketing
campaigns, the signing of definitive agreements with additional
distributors, and both the perceived need for EFP's products and the
competitive performance of such products in the marketplace.

KEYWORD: NORTH AMERICA CENTRAL AMERICA NEVADA UNITED STATES MEXICO
INDUSTRY KEYWORD: HEALTH MANUFACTURING PRODUCT/SERVICE
SOURCE: Emergency Filtration Products, Inc.

CONTACT INFORMATION:
Emergency Filtration Products, Inc.
Wendy Harper, 702-558-5164
(Fax) 702-567-1893
contactus@emergencyfiltration.com
www.emergencyfiltration.com
or
PAN Consultants, Ltd.
Philippe Niemetz, 800-477-7570, 212-344-6464
(Fax) 212-618-1276
p.niemetz@panconsultants.com

gad